Year |
Citation |
Score |
2023 |
Bhowmick S, Biswas T, Ahmed M, Roy D, Mondal S. Caveolin-1 and lipids: Association and their dualism in oncogenic regulation. Biochimica Et Biophysica Acta. Reviews On Cancer. 1878: 189002. PMID 37848094 DOI: 10.1016/j.bbcan.2023.189002 |
0.363 |
|
2023 |
Pal S, Bhowmick S, Sharma A, Sierra-Fonseca JA, Mondal S, Afolabi F, Roy D. Lymphatic vasculature in ovarian cancer. Biochimica Et Biophysica Acta. Reviews On Cancer. 188950. PMID 37419192 DOI: 10.1016/j.bbcan.2023.188950 |
0.326 |
|
2022 |
Sengupta B, Biswas P, Roy D, Lovett J, Simington L, Fry DR, Travis K. Anticancer Properties of Kaempferol on Cellular Signaling Pathways. Current Topics in Medicinal Chemistry. PMID 36082856 DOI: 10.2174/1568026622666220907112822 |
0.391 |
|
2022 |
Roy D, Jenkins B, Ali A, Herschmann JR, Harris M, Zamadar M, Simington L, Odunuga O, Adhikari P, Pradhan P, Sarkar S, Pattabiram M, Sengupta B. Multi-component redox system for selective and potent antineoplastic activity towards ovarian cancer cells. Biochemical and Biophysical Research Communications. 592: 38-43. PMID 35026603 DOI: 10.1016/j.bbrc.2022.01.007 |
0.338 |
|
2021 |
Ray U, Jung DB, Jin L, Xiao Y, Dasari S, Sarkar Bhattacharya S, Thirusangu P, Staub JK, Roy D, Roy B, Weroha SJ, Hou X, Purcell JW, Bakkum-Gamez JN, Kaufmann SH, et al. Targeting LRRC15 inhibits metastatic dissemination of ovarian cancer. Cancer Research. PMID 34654724 DOI: 10.1158/0008-5472.CAN-21-0622 |
0.336 |
|
2021 |
Ray U, Roy D, Jin L, Thirusangu P, Staub J, Xiao Y, Kalogera E, Wahner Hendrickson AE, Cullen GD, Goergen K, Oberg AL, Shridhar V. Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization. Journal of Experimental & Clinical Cancer Research : Cr. 40: 182. PMID 34082797 DOI: 10.1186/s13046-021-01985-9 |
0.332 |
|
2020 |
Hoffmann R, Sarkar Bhattacharya S, Roy D, Winterhoff B, Schmidmaier R, Dredge K, Hammond E, Shridhar V. Sulfated glycolipid PG545 induces endoplasmic reticulum stress and augments autophagic flux by enhancing anticancer chemotherapy efficacy in endometrial cancer. Biochemical Pharmacology. 114003. PMID 32360360 DOI: 10.1016/J.Bcp.2020.114003 |
0.431 |
|
2020 |
Adhikari P, Hasan M, Shridhar V, Roy D, Pradhan P. Nanoscale structural alterations in cancer cells to assess anti-cancerous drug effectiveness in ovarian cancer treatment using TEM imaging. Physical Biology. PMID 31931492 DOI: 10.1088/1478-3975/Ab6Abb |
0.438 |
|
2019 |
Sarkar Bhattacharya S, Thirusangu P, Jin L, Roy D, Jung D, Xiao Y, Staub J, Roy B, Molina JR, Shridhar V. PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses. Cell Death & Disease. 10: 725. PMID 31562297 DOI: 10.1038/S41419-019-1916-3 |
0.452 |
|
2019 |
Mariani A, Wang C, Oberg AL, Riska SM, Torres M, Kumka J, Multinu F, Sagar G, Roy D, Jung DB, Zhang Q, Grassi T, Visscher DW, Patel VP, Jin L, et al. Genes associated with bowel metastases in ovarian cancer. Gynecologic Oncology. PMID 31204077 DOI: 10.1016/J.Ygyno.2019.06.010 |
0.357 |
|
2018 |
Chatterjee A, Roy D, Guevara P, Pal R, Naryan M, Roychowdhury S, Das S. Arachidonic Acid Induces the Migration of MDA-MB-231 Cells by Activating Raft-associated Leukotriene B4 Receptors. Clinical Cancer Drugs. 5: 28-41. PMID 30443489 DOI: 10.2174/2212697X05666180418145601 |
0.67 |
|
2018 |
Mondal S, Roy D, Sarkar Bhattacharya S, Jin L, Jung D, Zhang S, Kalogera E, Staub J, Wang Y, Xuyang W, Khurana A, Chien J, Telang S, Chesney J, Tapolsky G, et al. Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers. International Journal of Cancer. PMID 30226266 DOI: 10.1002/Ijc.31868 |
0.524 |
|
2018 |
Jung D, Khurana A, Roy D, Kalogera E, Bakkum-Gamez J, Chien J, Shridhar V. Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancer. Scientific Reports. 8: 2487. PMID 29410485 DOI: 10.1038/S41598-018-20531-W |
0.348 |
|
2018 |
Kalogera E, Roy D, Bakkum-Gamez JN, Cliby BA, Dowdy SC, Shridhar V. Atorvastatin antagonizes carboplatin, synergizes with the glycolytic inhibitor pfk-158 and induces lipid laden multilamellar bodies in ovarian cancer Gynecologic Oncology. 149: 632-633. DOI: 10.1016/J.Ygyno.2018.03.041 |
0.429 |
|
2017 |
Kalogera E, Roy D, Khurana A, Mondal S, Weaver AL, He X, Dowdy SC, Shridhar V. Quinacrine in endometrial cancer: Repurposing an old antimalarial drug. Gynecologic Oncology. PMID 28545688 DOI: 10.1016/J.Ygyno.2017.04.022 |
0.407 |
|
2017 |
Roy D, Mondal S, Khurana A, Jung DB, Hoffmann R, He X, Kalogera E, Dierks T, Hammond E, Dredge K, Shridhar V. Loss of HSulf-1: The Missing Link between Autophagy and Lipid Droplets in Ovarian Cancer. Scientific Reports. 7: 41977. PMID 28169314 DOI: 10.1038/Srep41977 |
0.524 |
|
2016 |
Roy D, Khurana A, Kalogera E, Wen X, Mondal S, Shridhar V. Abstract B74: Can we repurpose anti-malarial drug quinacrine to treat ovarian cancer? Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-B74 |
0.443 |
|
2016 |
Kalogera E, Roy D, Khurana A, Mondal S, He X, Dowdy SC, Shridhar V. Abstract 261: Quinacrine in endometrial cancer: repurposing an old antimalarial drug Cancer Research. 76: 261-261. DOI: 10.1158/1538-7445.Am2016-261 |
0.358 |
|
2015 |
Khurana A, Roy D, Kalogera E, Mondal S, Wen X, He X, Dowdy S, Shridhar V. Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth. Oncotarget. PMID 26497553 DOI: 10.18632/Oncotarget.5632 |
0.44 |
|
2015 |
Mondal S, Roy D, Camacho-Pereira J, Khurana A, Chini E, Yang L, Baddour J, Stilles K, Padmabandu S, Leung S, Kalloger S, Gilks B, Lowe V, Dierks T, Hammond E, et al. HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer. Oncotarget. 6: 33705-19. PMID 26378042 DOI: 10.18632/Oncotarget.5605 |
0.426 |
|
2015 |
Winterhoff B, Freyer L, Hammond E, Giri S, Mondal S, Roy D, Teoman A, Mullany SA, Hoffmann R, von Bismarck A, Chien J, Block MS, Millward M, Bampton D, Dredge K, et al. PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples. European Journal of Cancer (Oxford, England : 1990). 51: 879-92. PMID 25754234 DOI: 10.1016/J.Ejca.2015.02.007 |
0.375 |
|
2015 |
Mondal S, Roy D, Kalogera E, Khurana A, Tapolsky GH, Telang S, Chesney J, Shridhar V. Abstract 2706: Inhibition of PFKFB3/glycolysis overcomes chemoresistance in ovarian cancers Cancer Research. 75: 2706-2706. DOI: 10.1158/1538-7445.Am2015-2706 |
0.466 |
|
2015 |
Roy D, Mondal S, Khurana A, He X, Hammond E, Dredge K, Shridhar V. Abstract 1135: Loss of HSulf-1 promotes defective autophagy and increased lipid droplet biogenesis in ovarian cancer Cancer Research. 75: 1135-1135. DOI: 10.1158/1538-7445.Am2015-1135 |
0.535 |
|
2014 |
Roy D, Mondal S, Wang C, He X, Khurana A, Giri S, Hoffmann R, Jung DB, Kim SH, Chini EN, Periera JC, Folmes CD, Mariani A, Dowdy SC, Bakkum-Gamez JN, et al. Erratum to: Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer. Cancer & Metabolism. 2: 24. PMID 26075069 DOI: 10.1186/2049-3002-2-24 |
0.313 |
|
2014 |
Roy D, Mondal S, Wang C, He X, Khurana A, Giri S, Hoffmann R, Jung DB, Kim SH, Chini EN, Periera JC, Folmes CD, Mariani A, Dowdy SC, Bakkum-Gamez JN, et al. Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer. Cancer & Metabolism. 2: 13. PMID 25225614 DOI: 10.1186/2049-3002-2-13 |
0.449 |
|
2014 |
He X, Khurana A, Roy D, Kaufmann S, Shridhar V. Loss of HSulf-1 expression enhances tumorigenicity by inhibiting Bim expression in ovarian cancer. International Journal of Cancer. Journal International Du Cancer. 135: 1783-9. PMID 24596063 DOI: 10.1002/Ijc.28818 |
0.421 |
|
2014 |
Roy D, Kabiraj P, Pal R. EF24 prevents rotenone-induced estrogenic status alteration in breast cancer. Cell Biology International. 38: 511-9. PMID 24375813 DOI: 10.1002/Cbin.10224 |
0.329 |
|
2014 |
Mondal S, Roy D, Pereira JC, Chini EN, Shridhar V. Abstract 3360: Loss of sulf-1 reprograms energy metabolism in ovarian cancer Cancer Research. 74: 3360-3360. DOI: 10.1158/1538-7445.Am2014-3360 |
0.474 |
|
2014 |
Roy D, He X, Khurana A, Mondal S, Jung D, Kim S, Dierks T, Folmes C, Terzic A, Shridhar V. Abstract 2439: HSulf-1 loss in ovarian cancer cells induces lipid droplet biogenesis Cancer Research. 74: 2439-2439. DOI: 10.1158/1538-7445.Am2014-2439 |
0.537 |
|
2013 |
Mendez TL, De Chatterjee A, Duarte TT, Gazos-Lopes F, Robles-Martinez L, Roy D, Sun J, Maldonado RA, Roychowdhury S, Almeida IC, Das S. Glucosylceramide transferase activity is critical for encystation and viable cyst production by an intestinal protozoan, Giardia lamblia. The Journal of Biological Chemistry. 288: 16747-60. PMID 23589290 DOI: 10.1074/Jbc.M112.438416 |
0.637 |
|
2011 |
Yichoy M, Duarte TT, De Chatterjee A, Mendez TL, Aguilera KY, Roy D, Roychowdhury S, Aley SB, Das S. Lipid metabolism in Giardia: a post-genomic perspective. Parasitology. 138: 267-78. PMID 20880419 DOI: 10.1017/S0031182010001277 |
0.636 |
|
2011 |
Roy D, De CA, Pal R, Roychowdhury S, Das S. P4-05-04: Arachidonic Acid-Induced Elevated Expression of 5-Lipoxygenase Is Linked to Metastatic Migration of Breast Cancer Cells. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P4-05-04 |
0.672 |
|
Show low-probability matches. |